Methacrylic Acid

Methacrylic Acid

SCHEMBL538882

C=C(C)C(=O)O.C=C(C)C(=O)O.CCC(O)CO

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.39
LMNA P02545 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TET2 Q6N021 5/20 0.34
OR51E2 Q9H255 1/20 0.33
TET3 O43151 1/20 0.32
TET1 Q8NFU7 1/20 0.32
KDM4E B2RXH2 1/20 0.32
DUSP3 P51452 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL18140688 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL18141633 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL18141554 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL4365784 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL18140925 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL18140955 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL18140819 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL9779196 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL18139451 1.00 TGFBR1 (0.39) TGFBR1LMNAALDH1A1TET2OR51E2
Methacrylic Acid SCHEMBL35386 0.88 LMNA (0.47) TGFBR1LMNAALDH1A1TET2OR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4537855-A PHOTOPOLYMERIZABLE HIGH MOLECULAR WEIGHT COMPOUND HAVING POLYFUCTIONAL ETHYLENICALLY UNSATURATED SIDE CHAIN OR END GROUPS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1985-08-27 US claimed
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2026-05-14 US disclosed
EP-4555021-B1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2026-05-13 EP disclosed
US-20260008936-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX BASF SE (DE) 2026-01-08 US disclosed
EP-4337734-B1 COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES BASF SE (DE) 2025-04-23 EP disclosed
US-20240309174-A1 COMPOSITIONS, COMPRISING SILVER NANOPLATELETS BASF SE (DE) 2024-09-19 US disclosed
EP-4423176-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2024-09-04 EP disclosed
US-20240287281-A1 COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES BASF SE (DE) 2024-08-29 US disclosed
CN-117425686-A Method for producing superabsorbent polymer and superabsorbent polymer 株式会社LG化学 2024-01-19 CN disclosed
CN-117377718-A Method for producing superabsorbent polymer and superabsorbent polymer 株式会社LG化学 2024-01-09 CN disclosed
EP-0106351-B1 PHOTOPOLYMERIZABLE PHOTOSENSITIVE COMPOSITION MITSUBISHI KASEI CORPORATION (JP) 1987-08-26 EP disclosed
EP-0211615-A2 Photopolymerisable composition Nippon Paint Co., Ltd. (JP) 1987-02-25 EP disclosed
US-4599368-A Marine anti-fouling coating formulations containing a soluble phase including a organotin polymer in combination with an insoluble phase including a crosslinked organotin polymer MIDWEST RESEARCH INSTITUTE (US) 1986-07-08 US disclosed
EP-0186637-A1 Marine anti-fouling coating formulations containing a soluble phase including a organotin polymer in combination with an insoluble phase including a crosslinked organotin polymer Midwest Research Institute (US) 1986-07-02 EP disclosed
EP-0179448-A2 Photosensitive planographic printing plate MITSUBISHI KASEI CORPORATION (JP) 1986-04-30 EP disclosed
EP-0071236-B1 PHOTOSENSITIVE LITHOGRAPHIC PLATE MITSUBISHI KASEI CORPORATION (JP) 1986-04-23 EP disclosed
US-4537855-A PHOTOPOLYMERIZABLE HIGH MOLECULAR WEIGHT COMPOUND HAVING POLYFUCTIONAL ETHYLENICALLY UNSATURATED SIDE CHAIN OR END GROUPS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1985-08-27 US disclosed
EP-0106351-A2 Photopolymerizable photosensitive composition MITSUBISHI KASEI CORPORATION (JP) 1984-04-25 EP disclosed
US-4421841-A UNSATURATED POLYESTERS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1983-12-20 US disclosed
EP-0071236-A1 Photosensitive lithographic plate MITSUBISHI KASEI CORPORATION (JP) 1983-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS COPE, COPB2, C9 TGFBR1 1246/4885LMNA 302/4885ALDH1A1 1943/4885
US-20260008936-A1 UV-CURABLE COATINGS HAVING HIGH REFRACTIVE INDEX B2M, MGMT, ITGAM TGFBR1 89/4885LMNA 1528/4885ALDH1A1 902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.